Vaccine policy, Medicare drug negotiations, and a potential DTC advertising ban will all fall under Kennedy’s purview as HHS ...

Food and drug companies have expressed optimism, but the new health secretary and his MAHA movement will likely make waves.

RFK Jr. will run the federal agency responsible for drug approvals, Medicare and Medicaid, vaccination guidance, ...

As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives ...

To distract from his larger plan to gut the federal government, the President has taken a relatively powerless program and turned it into an excuse for everything that goes wrong in the country.

Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...

After a tense election campaign against Democratic candidate Kamala Harris, Donald Trump is once again President of the United States as of 20 January 2025. For some this is the preferred outcome.

The UK Chancellor’s messaging at Davos recalled former Taoiseach Enda Kenny’s efforts to extol the recovery of the Irish ...

We recently published a list of Why Are These 10 Dividend Stocks Declining? In this article, we are going to take a look at ...